Opportunity Radar

← Back to search

Grant forecast

Studies Addressing Rare Neurodegenerative Diseases including ALS

View on Grants.gov ↗ Sign in to save

Type
Grant forecast
Notice type
G
Agency
Food and Drug Administration
Sub-agency
HHS-FDA
Solicitation #
FOR-FD-25-006
Posted
Aug 14, 2024
CFDA / Assistance listing
93.103
Contact
Terrin Brown Grantor · terrin.brown@fda.hhs.gov · 2404027610
Source
Grants.gov

Description

The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.

Similar open opportunities